Organovo Logo (2 Color Med-Res-082117).png
Organovo Announces Preliminary Fiscal Second-Quarter Total Revenue; Company Restructures to Improve Operational Efficiency
October 04, 2017 17:05 ET | Organovo, Inc.
SAN DIEGO, Oct. 04, 2017 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (NASDAQ:ONVO) (“Organovo”) today reported preliminary unaudited total revenue for the fiscal second quarter of 2018.  The Company...
Organovo Logo (2 Color Med-Res-082117).png
Organovo Sponsors Pioneering Research With Amgen and Medikine in Critical Areas of Liver and Kidney Disease
August 23, 2017 08:05 ET | Organovo, Inc.
SAN DIEGO, Aug. 23, 2017 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (NASDAQ:ONVO) (“Organovo”) today announced it has awarded the 2017 ExVive 3D Tissue Application Award to researchers at Amgen,...
Organovo Logo (2 Color Med-Res-082117).png
Organovo Announces Fiscal First-Quarter 2018 Results; Company Affirms Full-Year Fiscal 2018 Outlook
August 09, 2017 16:05 ET | Organovo, Inc.
SAN DIEGO, Aug. 09, 2017 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (NASDAQ:ONVO) (“Organovo”) today reported financial results for the fiscal first quarter of 2018 and affirmed its full-year...
Organovo Logo (2 Color Med-Res-082117).png
Organovo and UC San Diego Receive $1.7 Million Grant From National Institutes of Health to Study Liver Disease
July 31, 2017 08:05 ET | Organovo, Inc.
SAN DIEGO, July 31, 2017 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (NASDAQ:ONVO) (“Organovo”) today announced it has received a three-year, $1.7 million grant from the National Institutes of...
Organovo Logo (2 Color Med-Res-082117).png
Organovo Announces Release Date for Fiscal First-Quarter 2018 Financial Results
July 18, 2017 08:05 ET | Organovo, Inc.
SAN DIEGO, July 18, 2017 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (NASDAQ:ONVO) (“Organovo”) will host a conference call on Wednesday, August 9, 2017 at 5:00 p.m. Eastern Time (ET) to discuss the...
Organovo Logo (2 Color Med-Res-082117).png
Organovo Announces Fiscal Fourth-Quarter and Full-Year 2017 Results; Company Issues Full-Year Fiscal 2018 Outlook
June 07, 2017 16:05 ET | Organovo, Inc.
SAN DIEGO, June 07, 2017 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (NASDAQ:ONVO) (“Organovo”) today reported financial results for the fiscal fourth quarter of 2017 and issued its full-year fiscal...
Organovo Logo (2 Color Med-Res-082117).png
Organovo to Present at Jefferies Healthcare Conference
June 05, 2017 08:05 ET | Organovo, Inc.
SAN DIEGO, June 05, 2017 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (NASDAQ:ONVO) (“Organovo”), a three-dimensional biology company focused on delivering scientific and medical breakthroughs using...
Organovo Logo (2 Color Med-Res-082117).png
Organovo Presents New Preclinical Data on 3D Bioprinted Human Liver Tissues at World Advanced Therapies and Regenerative Medicine Congress
May 18, 2017 08:05 ET | Organovo, Inc.
SAN DIEGO, May 18, 2017 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (NASDAQ:ONVO) (“Organovo”), a three-dimensional biology company focused on delivering scientific and medical breakthroughs...
Organovo Logo (2 Color Med-Res-082117).png
Organovo Announces Release Date for Fiscal Fourth-Quarter 2017 Financial Results
May 17, 2017 08:05 ET | Organovo, Inc.
SAN DIEGO, May 17, 2017 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (NASDAQ:ONVO) (“Organovo”), a three-dimensional biology company focused on delivering scientific and medical breakthroughs using...
Organovo Logo (2 Color Med-Res-082117).png
Organovo Collaborates With University of Virginia to Develop Bioprinted Tissues for Volumetric Muscle Loss Injury
May 01, 2017 08:05 ET | Organovo, Inc.
SAN DIEGO, May 01, 2017 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (NASDAQ:ONVO) (“Organovo”), a three-dimensional biology company focused on delivering scientific and medical breakthroughs...